Related Experiment Video
Updated: Dec 19, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Ulmus parvifolia Modulates Platelet Functions and Inhibits Thrombus Formation by Regulating Integrin αIIbβ3 and cAMP
Muhammad Irfan1, Hyuk-Woo Kwon2, Dong-Ha Lee3
1Laboratory of Physiology and Cell Signaling, College of Veterinary Medicine, Kyungpook National University, Daegu, South Korea.
Insights
Ulmus parvifolia extract inhibits platelet aggregation and thrombus formation by regulating key signaling pathways. This natural compound shows potential for developing safer cardiovascular disease treatments.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Natural Product Chemistry
Background:
- Cardiovascular diseases (CVDs) pose a growing health challenge, necessitating novel therapeutic strategies.
- Traditional ethnomedicinal remedies are increasingly explored for their potential to mitigate CVD risk.
- Ulmus parvifolia (Chinese Elm) exhibits various medicinal properties, but its anti-platelet activity remains uninvestigated.
Purpose of the Study:
- To evaluate the anti-platelet and anti-thrombotic pharmacological effects of Ulmus parvifolia bark extract.
- To elucidate the underlying molecular mechanisms of Ulmus parvifolia's action on platelet function.
Main Methods:
- Assessed platelet aggregation using light transmission aggregometry and scanning electron microscopy.
- Measured intracellular calcium mobilization, ATP release, and thromboxane-B2 production.
- Analyzed integrin αIIbβ3 activation, signaling pathway protein expression (MAPK, Src, PI3K/Akt), and cAMP signaling.
Main Results:
- Ulmus parvifolia extract dose-dependently inhibited human and rat platelet aggregation, calcium mobilization, and TxB2 production.
- The extract suppressed integrin αIIbβ3-mediated signaling, including fibrinogen binding and fibronectin adhesion.
- Ulmus parvifolia modulated key signaling pathways (MAPK, Src, PI3K/Akt) and elevated cAMP levels, reducing thrombus formation in vivo.
Conclusions:
- Ulmus parvifolia exhibits significant anti-platelet and anti-thrombotic properties.
- The extract functions by regulating integrin αIIbβ3 signaling and the cAMP pathway.
- Ulmus parvifolia represents a promising natural agent for managing thrombotic disorders.
Background:
The prevalence of cardiovascular diseases (CVDs) is increasing at a high rate, and the available treatment options, sometimes, have complications which necessitates the need to develop safer and efficacious approaches. Ethnomedicinal applications reportedly reduce CVD risk. Ulmus parvifolia Jacq. (Ulmaceae) commonly known as Chinese Elm or Lacebark Elm, is native to China, Japan, and Korea. It exhibits anti-inflammatory, antiviral, and anticancer properties, but its anti-platelet properties have not yet been elucidated.
Purpose:
To investigate the pharmacological anti-platelet and anti-thrombotic effects of U. parvifolia bark extract.
Study Design And Methods:
Human and rat washed platelets were prepared; light transmission aggregometry and scanning electron microscopy was performed to assess platelet aggregation and the change in platelet shape, respectively. Intracellular calcium mobilization, ATP release, and thromboxane-B2 production were also measured. Integrin αIIbβ3 activation was analyzed in terms of fibrinogen binding, fibronectin adhesion, and clot retraction. The expression of MAPK, Src, and PI3K/Akt pathway proteins was examined. Cyclic nucleotide signaling pathway was evaluated via cAMP elevation and VASP phosphorylation. Anti-thrombotic activity of the extract was evaluated in vivo using an arteriovenous shunt rat model, whereas its effect on hemostasis in mice was assessed via bleeding time assay.
Results:
U. parvifolia extract significantly inhibited human and rat platelet aggregation in a dose-dependent manner along with inhibition of calcium mobilization, dense granule secretion, and TxB2 production. Integrin αIIbβ3 mediated inside-out and outside-in signaling events, as evidenced by the inhibition of fibrinogen binding, fibronectin adhesion, and clot retraction. The extract significantly reduced phosphorylation of Src, MAPK (ERK, JNK, and p38MAPK), and PI3K/Akt pathway proteins. Cyclic-AMP levels were elevated in U. parvifolia-treated platelets, while PKAαβγ and VASPser157 phosphorylation was enhanced. U. parvifolia reduced thrombus weight in rats and moderately increased bleeding time in mice.
Conclusion:
U. parvifolia modulates platelet responses and inhibit thrombus formation by regulating integrin αIIbβ3 mediated inside-out and outside-in signaling events and cAMP signaling pathway.
More Related Videos
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
05:43An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
Published on: November 8, 2024
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Intracellular Signaling Affects Focal Adhesions
Some...
Clot Retraction and Fibrinolysis
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...